Modus Biological Membranes Ltd.

Other

Epigenetics Ltd.

Senyorina Ltd.

Avner Shenfeld

Meir Shinitzky

Jacob Stein

Reuven Padova

Eliahu Eisenberg

Tsvi Hirshfeld

The present invention discloses a non-GM method for producing a crop exhibiting improved traits compared to a control population of plants of the same crop species comprising the steps of providing a population of plants, exposing said population of plants to a predetermined light treatment regime by irradiating with artificial light in a specific wavelength range, monitoring at least one trait of said plants of step (b), comparing to said control population and selecting at least the top about 0.5%, preferably 1-2% plants having the best improved trait of said plants of previous step, propagating at least one subsequent generation of said at least 0.5%, preferably 1-2%, best improved trait plants, optionally repeating previous steps for least one subsequent generation, thereby obtaining a crop exhibiting an improved trait, wherein the improved trait is inheritable for at least one more generation, preferably for two or more generations, more preferably for 3 to 5 generations, and even more preferably for 6 to 8 generations.

Non-GM improved crops and methods for obtaining crops with improved inheritable traits

A lipid preparation comprising at least about 10% phosphatidic acid (PA) is used to treat human conditions or disease. Examples of such conditions or disease are withdrawal syndromes or cancer.

Method for the treatment of cancer using phosphatidic acid-comprising compositions

A method of treating an individual with an immune system with decreased activity by administering an effective amount of a lipid preparation derived from a natural source and enriched to contain at least 10% (w/w) phosphatidic acid (PA) is disclosed.

Lipid-based immune modulator composition

Phosphatidic acid-comprising compositions

Obesity is treated by the administration to a subject of a compound having the general formula (I): R.sub.4 --(CH.sub.2).sub.n --CO--N(R.sub.1)--CH(R.sub.2)--CO(--R.sub.3), wherein R.sub.1 represents H or CH.sub.3 ; R.sub.2 represents a side chain of a naturally occurring amino acid; R.sub.3 represents OH, OCH.sub.2 CH.sub.3 and NH.sub.2 ; n is 6-18; and R.sub.4 represents CH.sub.3 or a group having the general formula (II): R.sub.3 --CO--CH(R.sub.2)--N(R.sub.1)--CO--, wherein R.sub.1, R.sub.2 and R.sub.3 have the above meanings. The compounds of formula (I) wherein R.sub.4 is a group of formula (II), are novel compounds.

Anti-obesity drugs

There is provided a hermetically closed culture vessel in which miroorganisms are cultivated simultaneously or consecutively on a liquid culture medium and on one or more solid culture media. The culture vessel is transparent, and contains in its lower part a liquid culture medium. From the cap, closing the vessel, there extends downwardly an elongated support for the solid culture medium or media, which is essentially parallel with the central axis of the vessel, which terminates above the liquid culture medium. The growth on the solid culture medium is conveniently inspected from the side of the culture vessel.

Growing community of inventors

Rehovot, Israel

Avner Shenfeld